China’s current hepatitis B infection rate has dropped to a lower level

Release date: 2010-04-26


The hepatitis B sero-epide epidemiological survey conducted by the Ministry of Health showed that the HBsAg carrying rate in the Chinese population has been lower than 8%, and the HBsAg carrying rate in the population under 5 years old has been less than 1%, which fully indicates that the current level of hepatitis B infection in China has dropped to very high. At a low level, the control of hepatitis B has achieved remarkable results.
China was once a country with a high rate of hepatitis B infection. In 1992, the national sero-epidemiological survey population had a hepatitis B virus infection rate of 60%, a surface antigen carrier rate of 9.75%, and a national hepatitis B virus carrier of about 120 million people.
Under the guidance of the “prevention-based” health work policy, the Chinese health department has continuously strengthened the leadership of hepatitis B prevention and control work, formulated prevention and treatment plans, and adopted comprehensive measures to control the prevalence and spread of hepatitis B. The main measures are as follows:
The first is to strengthen the hepatitis B vaccination work for children. Hepatitis B vaccine vaccination for children is the main strategy for controlling hepatitis B. It is necessary not only to strengthen the routine immunization planning work, but also to improve the full-time vaccination rate of hepatitis B vaccine for school-age children, and to take measures to improve the maternal delivery rate of pregnant women and strive to improve the timely vaccination rate of the first dose of newborns.
The second is to strengthen supervision and management of medical and health institutions. Eliminate the spread of hepatitis B virus through the blood route, strictly implement the requirements of the "Infectious Diseases Prevention and Control Law" and the "Blood Donation Law" and other relevant laws and regulations, strengthen the supervision and treatment of blood collection and blood supply institutions and blood product production units; medical and health institutions and units at all levels The implementation of hospital infection management regulations to ensure medical safety, and in accordance with the relevant regulations and requirements, disinfection and medical waste recycling work; medical and preventive injection must use disposable syringes.
The third is to regulate the behavior of medical services according to law. Strengthen the access and supervision of medical institutions and their employees engaged in the diagnosis and treatment of viral hepatitis, and strengthen the supervision and inspection of the standardized medical services and services of medical institutions and medical personnel at all levels. The Chinese Medical Association develops guidelines for the diagnosis and treatment of hepatitis B, and medical staff at all levels of medical institutions conduct standardized treatment of hepatitis B patients according to the guidelines.
The fourth is to strengthen publicity and education and carry out training. Adhere to the combination of universal health education and key population education, and carry out regular publicity work in various forms in a planned and targeted manner. Communicate the harm and prevention methods of hepatitis B to the masses, let the masses understand the ways of hepatitis B transmission and correct prevention methods, and enhance their awareness of self-protection.
After the implementation of the above measures, the vaccination rate of hepatitis B vaccine in China has increased year by year. According to the data of the project area in 2009, the full-time vaccination rate of newborn hepatitis B vaccine reached 98%, and the timely vaccination rate of hepatitis B vaccine reached 88%.
In 2006, the Ministry of Health organized a hepatitis B sero-epide epidemiological survey to show that the HBsAg carrying rate in Chinese population has been less than 8%, and the HBsAg carrying rate in people under 5 years old has been less than 1%, which fully indicates that the current level of hepatitis B infection has declined in China. To a very low level. According to the 2006 survey of HBsAg carrying rate and HBV prevalence rate, the number of people infected with hepatitis B virus in China has decreased by nearly 80 million since 1992, and the number of HBsAg carriers has decreased by 19 million. The control of hepatitis B has achieved remarkable results. Meditech Medical Network

Hair Removed Device:

IPL Hair Removal Machine is a kind of broad-spectrum visible light with a wavelength between 560 – 1200 nm. According to the principle of photothermal effect, IPL can selectively act on hair follicles and hair rods rich in melanin granule cells to produce local micro-explosion and destroy hair follicle tissue, So as to achieve effective hair removal effect.


Hair Removed Device

IPL Hair Removal Device

Ipl Machine,Hair Removed Device,Hair Removal Machine,Ipl Hair Removal

Shenzhen Guangyang Zhongkang Technology Co., Ltd , https://www.lighttherapymachine.com